DE60308828D1 - Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung - Google Patents

Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung

Info

Publication number
DE60308828D1
DE60308828D1 DE60308828T DE60308828T DE60308828D1 DE 60308828 D1 DE60308828 D1 DE 60308828D1 DE 60308828 T DE60308828 T DE 60308828T DE 60308828 T DE60308828 T DE 60308828T DE 60308828 D1 DE60308828 D1 DE 60308828D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
sustained release
oral pharmaceutical
coating agent
layer containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308828T
Other languages
English (en)
Other versions
DE60308828T2 (de
Inventor
Sandrine Salle
Emmanuel Guerin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Toray Industries Inc
Original Assignee
Ethypharm SAS
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS, Toray Industries Inc filed Critical Ethypharm SAS
Application granted granted Critical
Publication of DE60308828D1 publication Critical patent/DE60308828D1/de
Publication of DE60308828T2 publication Critical patent/DE60308828T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60308828T 2003-05-20 2003-05-20 Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung Expired - Lifetime DE60308828T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291180A EP1479383B1 (de) 2003-05-20 2003-05-20 Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung

Publications (2)

Publication Number Publication Date
DE60308828D1 true DE60308828D1 (de) 2006-11-16
DE60308828T2 DE60308828T2 (de) 2007-05-24

Family

ID=33041114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308828T Expired - Lifetime DE60308828T2 (de) 2003-05-20 2003-05-20 Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung

Country Status (9)

Country Link
US (1) US9616071B2 (de)
EP (1) EP1479383B1 (de)
JP (1) JP5013871B2 (de)
CN (1) CN100475197C (de)
AT (1) ATE341312T1 (de)
CA (1) CA2525542C (de)
DE (1) DE60308828T2 (de)
ES (1) ES2272914T3 (de)
WO (1) WO2004103350A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
DE102006035549A1 (de) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
EP2127643A1 (de) * 2008-05-30 2009-12-02 Bayer Schering Pharma Aktiengesellschaft Orale Pelletformulierungen mit zeitversetzter Wirkstofffreigabe
EP2198859A1 (de) 2008-12-17 2010-06-23 Losan Pharma GmbH Schmelzbeschichtete pharmazeutische Zusammensetzung mit Freisetzung
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
JP5780775B2 (ja) * 2011-02-18 2015-09-16 株式会社Ｌｔｔバイオファーマ プロスタグランジンｉ２誘導体を含有するナノ粒子
CN103127220B (zh) * 2011-12-05 2014-12-31 上海中医药大学 一种用于中药丹参浸膏粉或颗粒的防潮包衣方法
KR20150089087A (ko) * 2012-11-30 2015-08-04 인스메드 인코포레이티드 프로스타사이클린 조성물 및 이를 이용하기 위한 방법
MX2020004912A (es) 2013-10-25 2021-05-21 Insmed Inc Compuestos derivados de prostaciclinas, y el uso de los mismo para el tratamiento de la hipertension pulmonar.
CA2967385C (en) 2014-11-18 2023-05-16 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
CN106822013B (zh) * 2015-11-30 2020-05-12 北京泰德制药股份有限公司 前列环素类似物缓释制剂
MX2021013329A (es) 2019-04-29 2022-03-17 Insmed Inc Composiciones de polvo seco de los profarmacos de treprostinil y métodos de uso de las mismas.
BR112022009753A2 (pt) 2019-12-23 2022-08-09 Toray Industries Fármaco para prevenir turno de diálise ou morte renal
TW202317089A (zh) 2021-06-16 2023-05-01 日商東麗股份有限公司 罹患慢性腎臟病的貓的治療方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920219A (ja) * 1982-07-26 1984-02-01 Shin Etsu Chem Co Ltd 腸溶性コ−テイング製剤の製造方法
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
JPH01287019A (ja) * 1988-05-12 1989-11-17 Tanabe Seiyaku Co Ltd 徐放性製剤
JPH01287021A (ja) * 1988-05-13 1989-11-17 Shin Etsu Chem Co Ltd ワックス複覆薬剤の製造方法
JPH02225416A (ja) * 1989-02-28 1990-09-07 Toray Ind Inc ５，６，７―トリノル―４，８―インタ―ｍ―フェニレンＰＧＩ↓２誘導体の経口用製剤
US5405617A (en) * 1991-11-07 1995-04-11 Mcneil-Ppc, Inc. Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
JPH05309314A (ja) * 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd コーティング方法
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
JP3471977B2 (ja) * 1995-06-02 2003-12-02 信越化学工業株式会社 液体状可塑剤を用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
US20010003588A1 (en) * 1996-09-12 2001-06-14 Smithkline Beecham Corporation Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
EP0947196B1 (de) * 1997-03-14 2009-06-17 Toray Industries, Inc. Zusammensetzung von prostaglandin-i-derivaten mit verzoegerter abgabe
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
JP2000103732A (ja) 1998-07-28 2000-04-11 Tanabe Seiyaku Co Ltd 腸内適所放出型製剤
US6634576B2 (en) * 2000-08-31 2003-10-21 Rtp Pharma Inc. Milled particles
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same

Also Published As

Publication number Publication date
EP1479383B1 (de) 2006-10-04
US20070269506A1 (en) 2007-11-22
CA2525542A1 (en) 2004-12-02
JP5013871B2 (ja) 2012-08-29
EP1479383A1 (de) 2004-11-24
CA2525542C (en) 2012-01-10
CN1791390A (zh) 2006-06-21
ATE341312T1 (de) 2006-10-15
ES2272914T3 (es) 2007-05-01
DE60308828T2 (de) 2007-05-24
US9616071B2 (en) 2017-04-11
WO2004103350A1 (en) 2004-12-02
CN100475197C (zh) 2009-04-08
JP2006528969A (ja) 2006-12-28

Similar Documents

Publication Publication Date Title
DE60308828D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
DK0939626T3 (da) Galenisk form til forlænget frigivelse af milnacipran
BR0312347A (pt) Composição farmacêutica oral, usos da espessura de revestimento de um material de revestimento dependente do ph de dissolução, de um material de revestimento, e de um material de polimetacrilato
ATE391496T1 (de) Geschmacksmaskierte pharmazeutische formulierungen
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
BR0308609A (pt) revestimento de semente de nitrogênio de liberação lenta
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
EE9900453A (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
FI964249A0 (fi) Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti
MY157881A (en) Compositions containing fluorine substituted olefins and methods and systems using same
HRP20040367B1 (en) Montelukast granule formulation
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
ATE109975T1 (de) Pharmazeutische formulierungen mit anhaltender freisetzung.
DE60323474D1 (de) Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
WO2007017331A3 (en) Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
CO5160317A1 (es) Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene
DE69831940D1 (de) Tablette mit verlängerter Wirkstoffabgabe im Magen
ATE350021T1 (de) Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
ES2194793T3 (es) Microcapsulas para la liberacion prolongada de farmacos.
TH108851A (th) สูตรผสมทางเภสัชกรรมชนิดใหม่ที่มีใบกัวไนด์และอนุพันธุ์ไธอะโซลิดีนไดโอน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition